Catalyst Wire Dossier Catalyst Wire Dossier

CIR-NA

nicotinic acid
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CIR-NA, covering 2024-11-27 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT) [Phase 2]

See pricing